Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04167150 · ClinicalTrials.gov registry record · NA

Tart Cherry Supplementation and Women's Bone Health Study

A NA study, sponsored by Oklahoma State University.

Completed
Registry status
NA
Development phase
33
Enrollment target

NCT04167150 is a NA study that has completed, run by Oklahoma State University. The registered enrollment target is 33 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04167150, a NA study, has completed, sponsored by Oklahoma State University.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target

Study Summary

In spite of aggressive approaches to prevent and treat osteoporosis, it remains one of the most costly and debilitating diseases associated with aging. The pursuit of alternative approaches for preventing bone loss has included the investigation of a number of promising plant-based foods that can be incorporated into the diet. This project is an extension of our pre-clinical studies with tart cherry, designed to determine whether the findings from our animal study can be extended to humans. Thus, the purpose of this project is to investigate the dose-dependent effect of tart cherry juice consumption on biomarkers of bone metabolism in women, aged 65-80 years. The hypothesis to be tested is that three months of tart cherry supplementation will improve bone biomarkers in a dose-dependent manner. Moreover, these improvements in bone metabolism will correspond to a decrease in markers of inflammation and oxidative stress.

Interventions

  • DIETARY_SUPPLEMENT tart cherry juice concentrate is a commercial product provided by King Orchards (Central Lake, MI)

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2017-06-06
Est. Completion 2018-05-31
Phase NA

Sponsor

Oklahoma State University

26 total trials

What the Registry Record Tells You About NCT04167150

The ClinicalTrials.gov registry entry for NCT04167150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oklahoma State University, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which tart cherry juice concentrate is a commercial product provided by King Orchards (Central Lake, MI) is the first listed.

NCT04167150 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04167150 about?

NCT04167150 is a clinical study titled "Tart Cherry Supplementation and Women's Bone Health Study". In spite of aggressive approaches to prevent and treat osteoporosis, it remains one of the most costly and debilitating diseases associated with aging. The pursuit of alternative approaches for preventing bone loss has included the investigation of a number of promising plant-based foods that can be...

What is the current status of trial NCT04167150?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2017-06-06. Estimated completion is 2018-05-31.

What interventions are being tested in trial NCT04167150?

The interventions under investigation include: tart cherry juice concentrate is a commercial product provided by King Orchards (Central Lake, MI) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04167150?

This trial is sponsored by Oklahoma State University, which has 26 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.